Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Graham

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Environmental Science & Technology|June 12, 2012
Early public impressions of terrestrial carbon capture and storage in a coal-intensive stateSanya R Carley, Rachel M Krause, David C Warren, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|October 15, 2013
"Not in (or under) my backyard": Geographic proximity and public acceptance of carbon capture and storage facilitiesRachel M Krause, Sanya R Carley, David C Warren, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 9, 2002
Assessing preferences for prevention versus treatment using willingness to payPhaedra S Corso, James K Hammitt, John D Graham, et al.
Optics Express|February 23, 2010
Tunable negative group index in metamaterial structures with large form birefringenceKirill Sinchuk, Richard Dudley, John D Graham, et al.
Optics Express|January 26, 2011
Internal field distribution measurement in 1-D strongly anisotropic sub-wavelength periodic structures of finite lengthMesfin Woldeyohannes, John O Schenk, Robert P Ingel, et al.
European Urology|January 9, 2018
Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 TrialAntoine Kass-Iliyya, Gordana Jovic, Claire Murphy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2007
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)David P Dearnaley, Matthew R Sydes, Ruth E Langley, et al.
The Lancet. Oncology|March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.
The Lancet. Oncology|May 8, 2007
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Matthew R Sydes, John D Graham, et al.
Lancet (London, England)|January 1, 2016
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trialNicholas D James, Matthew R Sydes, Noel W Clarke, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Environmental Science & Technology|June 12, 2012
Early public impressions of terrestrial carbon capture and storage in a coal-intensive stateSanya R Carley, Rachel M Krause, David C Warren, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|October 15, 2013
"Not in (or under) my backyard": Geographic proximity and public acceptance of carbon capture and storage facilitiesRachel M Krause, Sanya R Carley, David C Warren, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 9, 2002
Assessing preferences for prevention versus treatment using willingness to payPhaedra S Corso, James K Hammitt, John D Graham, et al.
Optics Express|February 23, 2010
Tunable negative group index in metamaterial structures with large form birefringenceKirill Sinchuk, Richard Dudley, John D Graham, et al.
Optics Express|January 26, 2011
Internal field distribution measurement in 1-D strongly anisotropic sub-wavelength periodic structures of finite lengthMesfin Woldeyohannes, John O Schenk, Robert P Ingel, et al.
European Urology|January 9, 2018
Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 TrialAntoine Kass-Iliyya, Gordana Jovic, Claire Murphy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2007
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)David P Dearnaley, Matthew R Sydes, Ruth E Langley, et al.
The Lancet. Oncology|March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.
The Lancet. Oncology|May 8, 2007
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Matthew R Sydes, John D Graham, et al.
Lancet (London, England)|January 1, 2016
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trialNicholas D James, Matthew R Sydes, Noel W Clarke, et al.
Pageof 3